Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation

In stroke survivors, rectus femoris (RF) spasticity is often implicated in gait pattern alterations such as stiff knee gait (SKG). Botulinum toxin type A (BoNT-A) is considered the gold standard for focal spasticity treatment. However—even if the accuracy of injection is crucial for BoNT-A efficacy—...

Full description

Bibliographic Details
Main Authors: Lucia Cosenza, Alessandro Picelli, Danila Azzolina, Marco Alessandro Minetto, Marco Invernizzi, Michele Bertoni, Andrea Santamato, Alessio Baricich
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/12/8/490
_version_ 1797560709767233536
author Lucia Cosenza
Alessandro Picelli
Danila Azzolina
Marco Alessandro Minetto
Marco Invernizzi
Michele Bertoni
Andrea Santamato
Alessio Baricich
author_facet Lucia Cosenza
Alessandro Picelli
Danila Azzolina
Marco Alessandro Minetto
Marco Invernizzi
Michele Bertoni
Andrea Santamato
Alessio Baricich
author_sort Lucia Cosenza
collection DOAJ
description In stroke survivors, rectus femoris (RF) spasticity is often implicated in gait pattern alterations such as stiff knee gait (SKG). Botulinum toxin type A (BoNT-A) is considered the gold standard for focal spasticity treatment. However—even if the accuracy of injection is crucial for BoNT-A efficacy—instrumented guidance for BoNT-A injection is not routinely applied in clinical settings. In order to investigate the possible implications of an inadequate BoNT-A injection on patients’ clinical outcome, we evaluated the ultrasound-derived RF characteristics (muscle depth, muscle thickness, cross-sectional area and mean echo intensity) in 47 stroke survivors. In our sample, we observed wide variability of RF depth in both hemiparetic and unaffected side of included patients (0.44 and 3.54 cm and between 0.25 and 3.16 cm, respectively). Moreover, our analysis did not show significant differences between treated and non-treated RF in stroke survivors. These results suggest that considering the inter-individual variability in RF muscle depth and thickness, injection guidance should be considered for BoNT-A treatment in order to optimize the clinical outcome of treated patients. In particular, ultrasound guidance may help the clinicians in the long-term follow-up of muscle quality.
first_indexed 2024-03-10T18:04:24Z
format Article
id doaj.art-9a7d4d2e05e3490795800d2e32dfb2ff
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-03-10T18:04:24Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-9a7d4d2e05e3490795800d2e32dfb2ff2023-11-20T08:39:13ZengMDPI AGToxins2072-66512020-07-0112849010.3390/toxins12080490Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic EvaluationLucia Cosenza0Alessandro Picelli1Danila Azzolina2Marco Alessandro Minetto3Marco Invernizzi4Michele Bertoni5Andrea Santamato6Alessio Baricich7Physical and Rehabilitation Medicine, Department of Scienze della Salute, University of Piemonte Orientale, 28100 Novara, ItalyNeuromotor and Cognitive Rehabilitation Research Center, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, ItalyDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, ItalyDivision of Physical Medicine and Rehabilitation, Department of Surgical Sciences, University of Turin, 10126 Turin, ItalyPhysical and Rehabilitation Medicine, Department of Scienze della Salute, University of Piemonte Orientale, 28100 Novara, ItalyPhysical Medicine and Rehabilitation, ASST Sette Laghi, 21100 Varese, ItalyPhysical Medicine and Rehabilitation Section, “OORR” Hospital, University of Foggia, 71122 Foggia, ItalyPhysical and Rehabilitation Medicine, Department of Scienze della Salute, University of Piemonte Orientale, 28100 Novara, ItalyIn stroke survivors, rectus femoris (RF) spasticity is often implicated in gait pattern alterations such as stiff knee gait (SKG). Botulinum toxin type A (BoNT-A) is considered the gold standard for focal spasticity treatment. However—even if the accuracy of injection is crucial for BoNT-A efficacy—instrumented guidance for BoNT-A injection is not routinely applied in clinical settings. In order to investigate the possible implications of an inadequate BoNT-A injection on patients’ clinical outcome, we evaluated the ultrasound-derived RF characteristics (muscle depth, muscle thickness, cross-sectional area and mean echo intensity) in 47 stroke survivors. In our sample, we observed wide variability of RF depth in both hemiparetic and unaffected side of included patients (0.44 and 3.54 cm and between 0.25 and 3.16 cm, respectively). Moreover, our analysis did not show significant differences between treated and non-treated RF in stroke survivors. These results suggest that considering the inter-individual variability in RF muscle depth and thickness, injection guidance should be considered for BoNT-A treatment in order to optimize the clinical outcome of treated patients. In particular, ultrasound guidance may help the clinicians in the long-term follow-up of muscle quality.https://www.mdpi.com/2072-6651/12/8/490muscle spasticitybotulinum toxin type Aultrasonographystrokerehabilitationstiff knee gait
spellingShingle Lucia Cosenza
Alessandro Picelli
Danila Azzolina
Marco Alessandro Minetto
Marco Invernizzi
Michele Bertoni
Andrea Santamato
Alessio Baricich
Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
Toxins
muscle spasticity
botulinum toxin type A
ultrasonography
stroke
rehabilitation
stiff knee gait
title Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
title_full Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
title_fullStr Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
title_full_unstemmed Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
title_short Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
title_sort rectus femoris characteristics in post stroke spasticity clinical implications from ultrasonographic evaluation
topic muscle spasticity
botulinum toxin type A
ultrasonography
stroke
rehabilitation
stiff knee gait
url https://www.mdpi.com/2072-6651/12/8/490
work_keys_str_mv AT luciacosenza rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation
AT alessandropicelli rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation
AT danilaazzolina rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation
AT marcoalessandrominetto rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation
AT marcoinvernizzi rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation
AT michelebertoni rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation
AT andreasantamato rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation
AT alessiobaricich rectusfemorischaracteristicsinpoststrokespasticityclinicalimplicationsfromultrasonographicevaluation